DistantNews
Support us
ReevesMed Seeks Approval for Next-Gen Surgical Robot 'STARK'
🇰🇷 South Korea /Technology

ReevesMed Seeks Approval for Next-Gen Surgical Robot 'STARK'

From Chosun Ilbo · () Korean

Translated from Korean, summarized and contextualized by DistantNews.

At a glance

News Named sources New plan
  • ReevesMed has applied for regulatory approval from South Korea's Ministry of Food and Drug Safety for its next-generation surgical robot, STARK.
  • STARK is a domestically developed surgical robot platform built on ReevesMed's proprietary core technology.
  • The robot platform expands on the company's existing ArtiSential, which has been used in over 300,000 clinical procedures domestically and internationally.

ReevesMed has submitted an application to South Korea's Ministry of Food and Drug Safety (MFDS) for regulatory approval of its next-generation surgical robot platform, STARK. This move marks a significant step for the company in bringing its advanced robotic surgical technology to the market.

The STARK platform is a domestically developed surgical robot, built upon ReevesMed's unique and proprietary core technologies. This indigenous development highlights South Korea's growing capabilities in high-tech medical device manufacturing. The company has leveraged its existing expertise to create this innovative system.

STARK is an expansion of ReevesMed's flagship product, the multi-jointed surgical instrument 'ArtiSential.' The ArtiSential technology has already proven its efficacy and reliability, having been utilized in over 300,000 clinical procedures both within South Korea and internationally. The successful track record of ArtiSential provides a strong foundation for the potential success of the STARK platform.

DistantNews Editorial

Originally published by Chosun Ilbo in Korean. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.

More Stories

From Our Blog